gsearch P.I.: Melanie Palomares, MD, MS studies
Palomares and colleagues will recruit 24 postmenopausal breast cancer survivors for this study. Women who were diagnosed with breast cancer five or more years ago and remain free of disease will be randomly assigned to take tablets containing varying doses of freeze-dried white button mushrooms daily for 12 weeks.
Researchers will monitor aromatase activity and female hormones in participants, as well as levels of what are called conjugated linoleic acids, a group of compounds in the mushrooms that appear to be responsible for their anticancer properties. They also will study effects on the immune system, cholesterol and bone health.
A second planned trial, meanwhile, will address prostate cancer. more
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction (LDTam)